ALK and neuroblastoma: In a deep sequencing study of primary NB, ALK F1174 and R1275 mutations were identified in 10% (27/277) of patients at allele frequencies ranging from 0.56% to 40.41%, half of which would have been undetectable by Sanger sequencing [81].